Expressable, a market leader in research-based, family-centered speech therapy care, announced it raised $26 million in Series B funding. HarbourVest Partners led the round, which included Digitalis Ventures and existing investors F-Prime Capital and Lerer Hippeau.
And Expressable’s novel speech therapy solution integrates virtual services with a comprehensive education and technology platform.
This funding round will support efforts to enhance the company’s technology-enabled care delivery platform, expand its clinical network of W2-employed speech-language pathologists, and accelerate its roster of health plan and provider partnerships across the country.
Research shows that supporting family-centered care is essential in improving pediatric speech outcomes, but millions of children in the US remain untreated or undertreated. And children with speech and language impairment suffer increased risk of learning disabilities, behavioral disorders, poor academic achievement, and impacts on socio-emotional health.
Expressable integrates virtual services with its comprehensive education and technology platform, enabling caregivers to incorporate therapy techniques into the home for faster positive outcomes and more cost-effective care.
Expressable has been leading the way in developing a better care model that improves the patient experience, with over 90% of patients achieving clinical progress towards their established care plans and thousands of 5-star reviews. And Expressable has partnered with hundreds of health plans nationwide, including Medicaid, to make high-quality therapy more accessible to everyone in need. Their therapy platform is now available in all 50 states to millions of families and individuals with timely, in-network coverage.
KEY QUOTES:
“Speech therapy has transformational impacts on a child’s life, yet too many children today are left severely underserved risking delayed outcomes and cost-intensive care. We’re grateful to HarbourVest and all of our investors for sharing in our mission of reinventing the current standard of care, a critical endeavor given speech therapy’s tremendous impact on healthy childhood development.”
– President and Chief Clinical Officer Leanne Sherred, M.S. CCC-SLP
“We’re thrilled to partner with Expressable as they continue to scale their category-defining speech therapy solution for this growing market need. Generating better outcomes through their novel care model is a win-win for patients, payers, and providers that aligns incentives and addresses disparities in access.”
– Michael Guiness, Principal at HarbourVest
